Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wimon Suwankesawong

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMC Complementary and Alternative Medicine|December 26, 2014
Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) databaseWimon Suwankesawong, Surasak Saokaew, Unchalee Permsuwan, et al.
Drug Safety|March 23, 2011
Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008Surasak Saokaew, Wimon Suwankesawong, Unchalee Permsuwan, et al.
Pharmacoepidemiology and Drug Safety|May 14, 2016
Pharmacovigilance activities in ASEAN countriesWimon Suwankesawong, Teerapon Dhippayom, Wei-Chuen Tan-Koi, et al.
International Journal of Environmental Research and Public Health|April 23, 2022
Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected CountriesWiwan Worakunphanich, Sitaporn Youngkong, Wimon Suwankesawong, et al.
Asian Pacific Journal of Allergy and Immunology|September 6, 2015
Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance DatabaseThet Su Zin Win, Nathorn Chaiyakunapruk, Wimon Suwankesawong, et al.
Regulatory Toxicology and Pharmacology : RTP|June 20, 2014
Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable riskSareeya Wechwithan, Wimon Suwankesawong, Vorasith Sornsrivichai, et al.
International Journal of Clinical Pharmacy|February 6, 2023
Thai stakeholders' awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative studyWiwan Worakunphanich, Wimon Suwankesawong, Sitaporn Youngkong, et al.
Drug Safety|April 26, 2013
Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center DatabasePornwalai Boonmuang, Surakit Nathisuwan, Nathorn Chaiyakunapruk, et al.
Public Health Genomics|October 25, 2014
Clinical application of pharmacogenomics: the example of HLA-based drug-induced toxicityMing Ta Michael Lee, Surakameth Mahasirimongkol, Yanfei Zhang, et al.
Pharmacogenetics and Genomics|June 19, 2015
Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactionsThachanan Kongpan, Surakameth Mahasirimongkol, Parinya Konyoung, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Complementary and Alternative Medicine|December 26, 2014
Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) databaseWimon Suwankesawong, Surasak Saokaew, Unchalee Permsuwan, et al.
Drug Safety|March 23, 2011
Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008Surasak Saokaew, Wimon Suwankesawong, Unchalee Permsuwan, et al.
Pharmacoepidemiology and Drug Safety|May 14, 2016
Pharmacovigilance activities in ASEAN countriesWimon Suwankesawong, Teerapon Dhippayom, Wei-Chuen Tan-Koi, et al.
International Journal of Environmental Research and Public Health|April 23, 2022
Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected CountriesWiwan Worakunphanich, Sitaporn Youngkong, Wimon Suwankesawong, et al.
Asian Pacific Journal of Allergy and Immunology|September 6, 2015
Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance DatabaseThet Su Zin Win, Nathorn Chaiyakunapruk, Wimon Suwankesawong, et al.
Regulatory Toxicology and Pharmacology : RTP|June 20, 2014
Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable riskSareeya Wechwithan, Wimon Suwankesawong, Vorasith Sornsrivichai, et al.
International Journal of Clinical Pharmacy|February 6, 2023
Thai stakeholders' awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative studyWiwan Worakunphanich, Wimon Suwankesawong, Sitaporn Youngkong, et al.
Drug Safety|April 26, 2013
Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center DatabasePornwalai Boonmuang, Surakit Nathisuwan, Nathorn Chaiyakunapruk, et al.
Public Health Genomics|October 25, 2014
Clinical application of pharmacogenomics: the example of HLA-based drug-induced toxicityMing Ta Michael Lee, Surakameth Mahasirimongkol, Yanfei Zhang, et al.
Pharmacogenetics and Genomics|June 19, 2015
Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactionsThachanan Kongpan, Surakameth Mahasirimongkol, Parinya Konyoung, et al.
Pageof 2